BRKR
Medical Devices · Healthcare
Analyst
Jefferies
Analyst
Wells Fargo
Equibles does not estimate personal net worth.
Brandon Couillard is recorded as Analyst at Jefferies and Analyst at Wells Fargo. Brandon Couillard has spoken on 19 earnings calls across 10 companies, most recently for Mettler Toledo International Inc/ on May 8, 2026. Those appearances were for Bruker Corp (BRKR), Bio-Rad Laboratories, Inc. (BIO), CareDx, Inc. (CDNA), Agilent Technologies, Inc. (A), Mettler Toledo International Inc/ (MTD) and 5 other companies. The companies whose calls Brandon Couillard spoke on are classified in the Healthcare sector.
“It'd be great to get some color on China. I think you mentioned revenues were down over 20%, but Gerald kind of alluded to a market improvement in orders. Just unpack what you're seeing across the end markets there and whether that's maybe starting to pick up a bit.”
“It'd be helpful if you could just maybe share any color on 2Q, 3Q, you know, revenue phasing. You do lack a tougher comp in the second quarter and are you kind of assuming that, you know, a fairly normal sequential seasonality for the business off of the 1Q base from here?”
“Did that region deteriorate sequentially, or is that just a year-over-year comment? And then the 50 basis points of weather impact in the U.S. in the quarter, I guess I would have thought you would have made up those orders at some point in the quarter.”
“John, on Nevaris, just curious how long this asset's been on your radar screen. Looks like they also operate two labs, one in Massachusetts, one in North Carolina.”
Jefferies
Analyst
Source not stated
Wells Fargo
Analyst
Source not stated
BRKR
Medical Devices · Healthcare
CDNA
Diagnostics & Research · Healthcare
Diagnostics & Research · Healthcare
AVTR
Medical Instruments & Supplies · Healthcare
RGEN
Medical Instruments & Supplies · Healthcare
RVTY
Diagnostics & Research · Healthcare
CDXS
Biotechnology · Healthcare
ALGN
Medical Instruments & Supplies · Healthcare